Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus
Robert V. Farese(University of South Florida), Mini P. Sajan(United States Department of Veterans Affairs), Mackenzie C. Lee(James A. Haley Veterans' Hospital)
Cited by 20
Related Papers
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
|Science|2012|1.7k
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
|Cancer Cell|2005|535
FoxO1 Regulates Multiple Metabolic Pathways in the Liver
|Journal of Biological Chemistry|2006|514
Licorice-Induced Hypermineralocorticoidism
|New England Journal of Medicine|1991|292
Activation of Protein Kinase C (α, β, and ζ) by Insulin in 3T3/L1 Cells
|Journal of Biological Chemistry|1997|289